01 1Cambrex Karlskoga AB
02 1DARMERICA, LLC
03 1Qingdao Biopeptek Co., Ltd.
01 2Tesofensine
02 1Tesofensine/NS2330 citrate
01 3U.S.A
NDC Package Code : 73212-039
Start Marketing Date : 2022-01-03
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 12651-121
Start Marketing Date : 2021-01-19
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 71052-207
Start Marketing Date : 2022-07-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
A Tesofensine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tesofensine, including repackagers and relabelers. The FDA regulates Tesofensine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tesofensine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Tesofensine supplier is an individual or a company that provides Tesofensine active pharmaceutical ingredient (API) or Tesofensine finished formulations upon request. The Tesofensine suppliers may include Tesofensine API manufacturers, exporters, distributors and traders.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Tesofensine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Tesofensine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Tesofensine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Tesofensine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Tesofensine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Tesofensine suppliers with NDC on PharmaCompass.
We have 3 companies offering Tesofensine
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
